430 reports of this reaction
3.8% of all KETAMINE HYDROCHLORIDE reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for KETAMINE HYDROCHLORIDE, manufactured by Par Health USA, LLC. There are 430 FDA adverse event reports linking KETAMINE HYDROCHLORIDE to NAUSEA. This represents approximately 3.8% of all 11,206 adverse event reports for this drug.
Patients taking KETAMINE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among KETAMINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for KETAMINE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 430 FDA reports for KETAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.8% of all adverse event reports for KETAMINE HYDROCHLORIDE, making it a notable side effect.
If you experience nausea while taking KETAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.